| Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down … H Tatebe, T Kasai, T Ohmichi, Y Kishi, T Kakeya, M Waragai, M Kondo, ... Molecular neurodegeneration 12, 1-11, 2017 | 251 | 2017 |
| Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases T Ohmichi, M Mitsuhashi, H Tatebe, T Kasai, OMA El-Agnaf, T Tokuda Parkinsonism & related disorders 61, 82-87, 2019 | 104 | 2019 |
| p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusions Y Watanabe, H Tatebe, K Taguchi, Y Endo, T Tokuda, T Mizuno, ... PloS one 7 (12), e52868, 2012 | 104 | 2012 |
| Extracellular neurosin degrades α-synuclein in cultured cells H Tatebe, Y Watanabe, T Kasai, T Mizuno, M Nakagawa, M Tanaka, ... Neuroscience research 67 (4), 341-346, 2010 | 99 | 2010 |
| The domestic cat as a natural animal model of Alzheimer’s disease JK Chambers, T Tokuda, K Uchida, R Ishii, H Tatebe, E Takahashi, ... Acta neuropathologica communications 3, 1-14, 2015 | 85 | 2015 |
| Differential expression of alpha-synuclein in hippocampal neurons K Taguchi, Y Watanabe, A Tsujimura, H Tatebe, S Miyata, T Tokuda, ... PloS one 9 (2), e89327, 2014 | 74 | 2014 |
| Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils A Tsujimura, K Taguchi, Y Watanabe, H Tatebe, T Tokuda, T Mizuno, ... Neurobiology of disease 73, 244-253, 2015 | 70 | 2015 |
| Decrease in plasma levels of α-synuclein is evident in patients with Parkinson’s disease after elimination of heterophilic antibody interference R Ishii, T Tokuda, H Tatebe, T Ohmichi, T Kasai, M Nakagawa, T Mizuno, ... PloS one 10 (4), e0123162, 2015 | 59 | 2015 |
| Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis K Murakami, M Tokuda, T Suzuki, Y Irie, M Hanaki, N Izuo, Y Monobe, ... Scientific reports 6 (1), 29038, 2016 | 58 | 2016 |
| Proteomic profiling of extracellular vesicles isolated from cerebrospinal fluid of former national football league players at risk for chronic traumatic encephalopathy S Muraoka, MP Jedrychowski, H Tatebe, AM DeLeo, S Ikezu, T Tokuda, ... Frontiers in neuroscience 13, 1059, 2019 | 52 | 2019 |
| Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS T Kasai, Y Kojima, T Ohmichi, H Tatebe, Y Tsuji, Y Noto, F Kitani‐Morii, ... Annals of clinical and translational neurology 6 (12), 2489-2502, 2019 | 48 | 2019 |
| Serum levels of coenzyme Q10 in patients with multiple system atrophy T Kasai, T Tokuda, T Ohmichi, R Ishii, H Tatebe, M Nakagawa, T Mizuno PLoS One 11 (1), e0147574, 2016 | 48 | 2016 |
| Increased levels of plasma total tau in adult Down syndrome T Kasai, H Tatebe, M Kondo, R Ishii, T Ohmichi, WTE Yeung, M Morimoto, ... PLoS One 12 (11), e0188802, 2017 | 47 | 2017 |
| Enhancement of alcohol drinking in mice depends on alterations in RNA editing of serotonin 2C receptors Y Watanabe, K Yoshimoto, H Tatebe, M Kita, K Nishikura, M Kimura, ... International Journal of Neuropsychopharmacology 17 (5), 739-751, 2014 | 35 | 2014 |
| Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients M Shinomoto, T Kasai, H Tatebe, M Kondo, T Ohmichi, M Morimoto, ... PloS one 14 (4), e0211575, 2019 | 26 | 2019 |
| Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics Y Kojima, T Kasai, Y Noto, T Ohmichi, H Tatebe, T Kitaoji, Y Tsuji, ... PLoS One 16 (11), e0260323, 2021 | 16 | 2021 |
| Proteomic profiling of extracellular vesicles separated from plasma of former national football league players at risk for chronic traumatic encephalopathy S Muraoka, AM DeLeo, Z Yang, H Tatebe, K Yukawa-Takamatsu, S Ikezu, ... Aging and disease 12 (6), 1363, 2021 | 15 | 2021 |
| Intrathecal nusinersen treatment after ventriculo-peritoneal shunt placement: a case report focusing on the neurofilament light chain in cerebrospinal fluid T Tozawa, T Kasai, H Tatebe, K Shiomi, H Nishio, T Tokuda, T Chiyonobu Brain and Development 42 (3), 311-314, 2020 | 14 | 2020 |
| Influx of tau and amyloid-β proteins into the blood during hemodialysis as a therapeutic extracorporeal blood amyloid-β removal system for Alzheimer’s disease N Kitaguchi, H Tatebe, K Sakai, K Kawaguchi, S Matsunaga, T Kitajima, ... Journal of Alzheimer's Disease 69 (3), 687-707, 2019 | 14 | 2019 |
| Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease T Ohmichi, T Kasai, T Kosaka, K Shikata, H Tatebe, R Ishii, M Shinomoto, ... PLoS One 13 (7), e0201260, 2018 | 14 | 2018 |
